RxDoctor Payments Data

Jessica Moskovitz, MD

Otolaryngology · Gretna, LANPI 1821382433

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inspire Medical Systems, Inc. accounts for 84.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $970, more than ten times the $24 reported in 2019.

$3,290in general payments, 2019–2025

Across 101 payments — averaging $32.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Medtronic$194
  • Aerin Medical Inc.$125
  • Optinose US, Inc.$108
  • Sobi, Inc$43
  • Baxter Healthcare$24
  • plus $22 from 1 others

What the payments were for

  • Food & beverage$3,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,290 in reported general payments places this provider in the 75th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$47,232
Medicare patients
120
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl507$12,917
Fluticasone Propionate557$8,389
Ipratropium Bromide76$1,607
Omeprazole65$1,045
Fluocinolone Acetonide Oil16$605
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip46$386
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$282
Pantoprazole Sodium31$264
Mupirocin32$233
Nystatin13$203
Levocetirizine Dihydrochloride29$197
Ondansetron OdtOndansetron19$153
Fluconazole11$123
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$103
Sodium FluorideFluoride (Sodium)11$8

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Gretna

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →